The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

Dicerna Pharma has enticed another big pharma to partner its RNA interference platform, attracting a $200 million upfront deal with Roche for a drug to treat hepatitis B virus infections.

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

Warminster-based Arbutus Biopharma laid off over half of its workforce and is exiting its headquarters to conserve cash while ...

Lamivudine oral tablet is a generic prescription drug used to treat HIV alongside other antiretroviral drugs, and to treat long-term hepatitis B. It’s usually taken once or twice per day.

Uncover what drives alcoholic hepatitis, how it’s detected, and why stopping alcohol is vital for better health and recovery.